<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RGNX
Regenxbio
$
()


  • Regenxbio's ABBV-RGX-314 featured in published study for wet AMD

    3/28/2024 - 07:09am
  • Regenxbio initiated with bullish view at H.C. Wainwright, here's why

    3/11/2024 - 09:34am
  • RBC Capital upgrades Regenxbio to Outperform, sees positive risk-reward

    3/8/2024 - 07:15am
  • RBC Capital gets more bullish on Regenxbio, upgrades shares

    3/8/2024 - 05:18am
  • Regenxbio price target raised by $10 at Barclays, here's why

    3/7/2024 - 07:01am
  • Regenxbio 4.57M share Spot Secondary priced at $23.00

    3/7/2024 - 06:08am
  • Regenxbio announces $125M common stock offering

    3/6/2024 - 16:11pm
  • Nvidia initiated, Target upgraded: Wall Street's top analyst calls

    3/6/2024 - 09:50am
  • Leerink more bullish on Regenxbio, upgrades to Outperform

    3/6/2024 - 08:09am
  • Leerink gets more bullish on Regenxbio, upgrades shares

    3/6/2024 - 08:03am
  • Regenxbio price target raised by $5 at Baird, here's why

    3/6/2024 - 06:57am
  • Regenxbio's RGX-202 shows initial efficacy in Duchenne

    3/5/2024 - 07:12am
  • Regenxbio expects cash to fund operations into 2H25

    2/27/2024 - 16:08pm
  • Regenxbio reports Q4 EPS ($1.34), consensus ($1.27)

    2/27/2024 - 16:06pm
  • Regenxbio resumed with an Outperform at Raymond James

    2/21/2024 - 05:21am
dynamic_feed Breaking News